Rare disease news, mapped to the diseases behind the headlines. AI-classified across pipeline, policy, funding, science, and community.
Be among the first to receive Kisho Intelligence Briefings
Showing news related to
Showing 1–6 of 6 stories
The National Institutes of Health has submitted a request for review to the Office of Management and Budget regarding the information collection for Autism Spectrum Disorder research. This is part of compliance with the Paperwork Reduction Act.
Read full storyThe CDC is seeking public comments on a proposed information collection project aimed at promoting resources for autistic teens and young adults. This initiative aligns with the Paperwork Reduction Act of 1995 and aims to enhance the utility of government information.
A recent systematic review confirms that the use of paracetamol during pregnancy does not increase the risk of autism, ADHD, or intellectual disability. The EMA maintains that paracetamol is a crucial option for managing pain or fever in pregnant women based on extensive scientific data.
The CDC has released new prevalence data on Autism Spectrum Disorders (ASDs) from multiple U.S. communities, marking the largest summary to date. This data is crucial for understanding the scope of ASDs and guiding future research and policy.
The CDC has awarded $5.9 million to five sites for a multi-state study aimed at identifying risk factors for autism spectrum disorders in children aged 2 to 5. This initiative will involve approximately 2,700 children and their parents.
A study reveals that children with autism spectrum disorders in metropolitan Atlanta face a 13-month delay between evaluation and diagnosis, with initial evaluations occurring at an average age of 4 years. This highlights significant gaps in timely diagnosis for ASDs.
Get the week's most important rare disease developments — pipeline moves, policy changes, and funding signals — delivered to your inbox every Monday.
Free weekly briefing. Unsubscribe anytime.